DrugPatentWatch Database Preview
Patents Expiring in 2026
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | AVYCAZ | avibactam sodium; ceftazidime | POWDER;IV (INFUSION) | 206494-001 | Feb 25, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | A METHOD OF TREATING BACTERIAL INFECTIONS IN COMPLICATED INTRA-ABDOMINAL INFECTION AND COMPLICATED URINARY TRACT INFECTION, INCLUDING PYELONEPHRITIS, PATIENTS COMPRISING ADMINISTERING A BACTERICIDALLY EFFECTIVE AMOUNT OF AVIBACTAM SODIUM | ||
| Allergan | AVYCAZ | avibactam sodium; ceftazidime | POWDER;IV (INFUSION) | 206494-001 | Feb 25, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | A METHOD OF TREATING BACTERIAL INFECTIONS IN HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNENUMONIA (HABP/VABP) PATIENTS COMPRISING ADMINISTERING A BACTERICIDALLY EFFECTIVE AMOUNT OF AVIBACTAM SODIUM | ||
| Allergan | AVYCAZ | avibactam sodium; ceftazidime | POWDER;IV (INFUSION) | 206494-001 | Feb 25, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | METHOD OF TREATING BACTERIAL INFECTIONS | ||
| Allergan | FETZIMA | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 204168-001 | Jul 25, 2013 | AB | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | |||
| Allergan | FETZIMA | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 204168-002 | Jul 25, 2013 | AB | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
